HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adipocyte insulin action in hypogonadotrophic hypogonadism.

Abstract
In-vitro studies of adipose tissue have shown that patients with polycystic ovarian syndrome (PCOS) have marked insulin resistance, the abnormalities being more pronounced during amenorrhoea compared to following an ovulatory cycle. If the insulin resistance in PCOS is a reflection of anovulation then patients with hypogonadotrophic hypogonadism (HH) should also have a reduction in insulin sensitivity. This study was designed to investigate insulin sensitivity in patients with HH. Seven patients with HH were studied and compared with eight age and body mass index matched female controls. Adipocyte insulin receptor binding was measured and adipocyte insulin action was assessed by measuring initial rates of 3-O-methylglucose uptake and inhibition of lipolysis. The specific insulin receptor binding per 10 cm(2) cell surface was 0.95 +/- 0. 25% in HH and 1.85 +/- 0.14% in control patients (P < 0.01). Maximum rates of glucose uptake were also impaired in HH compared with controls (3-O-methylglucose transport 0.81 +/- 0.22 versus 1.83 +/- 0.2 pmol/10 cm(2)/5 s)(P < 0.01). Hence, patients with HH have impaired insulin sensitivity to a degree similar to that seen in PCOS, suggesting a direct effect of anovulation on insulin sensitivity.
AuthorsP J Marsden, A P Murdoch, R Taylor
JournalHuman reproduction (Oxford, England) (Hum Reprod) Vol. 15 Issue 8 Pg. 1672-8 (Aug 2000) ISSN: 0268-1161 [Print] England
PMID10920084 (Publication Type: Journal Article)
Chemical References
  • Insulin
  • Androstenedione
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
  • Glucose
Topics
  • Adipocytes (physiology)
  • Adult
  • Amenorrhea (etiology, metabolism)
  • Androstenedione (blood)
  • Blood (metabolism)
  • Case-Control Studies
  • Female
  • Follicle Stimulating Hormone (blood)
  • Glucose (pharmacokinetics)
  • Humans
  • Hypogonadism (etiology, metabolism)
  • Insulin (metabolism)
  • Insulin Resistance
  • Lipid Metabolism
  • Luteinizing Hormone (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: